AstraZeneca approached Gilead about potential merger


2/2 © Reuters. FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen during the outbreak of the coronavirus disease (COVID-19), in California 2/2 By Paul Sandle and Pamela Barbaglia LONDON (Reuters) – Britain’s AstraZeneca Plc (L:) has approached U.S. rival Gilead Sciences Inc (O:) about a possible merger that wouldRead More →

The Gannett-GateHouse Merger Is Really Happening, And Expect To See More Than 10% Of Jobs Cut Off The Top – Gannett Co., Inc. (NYSE:GCI)


The megamerger is really happening. Expect the new Gannett (NYSE:GCI) – the brand that will survive that chain’s acquisition by GateHouse Media (NYSE:NEWM) – to officially take wobbly flight soon, perhaps around Thanksgiving. Both companies, the country’s No. 1 and No. 2 newspaper publishers, say it’s full speed ahead. IndependentRead More →

Merger Talk Boosts Pfizer – Pfizer Inc. (NYSE:PFE)


By Chris Quigley Upjohn manufactures older brands like Lipitor and Viagra, while Mylan (MYL) is best know for making generic drugs and for its EpiPen. Pfizer (PFE) shareholders will end up owning 57% of the combined entity. After the spinoff, Upjohn will make a $12 billion payment to Pfizer. AnalystsRead More →